| Dr Shelly Anne Birch, MD | |
|
303 N Clyde Morris Blvd, Daytona Beach, FL 32114-2709 | |
| (386) 425-4100 | |
| (386) 258-4875 |
| Full Name | Dr Shelly Anne Birch |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 303 N Clyde Morris Blvd, Daytona Beach, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548617038 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | ME141349 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uf Health Leesburg Hospital | Leesburg, FL | Hospital |
| Villages Regional Hospital, The | The villages, FL | Hospital |
| Adventhealth Ocala | Ocala, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Halifax Healthcare Systems Inc | 1254238090 | 278 |
| Paragon Emergency Services Llc | 8628153087 | 207 |
| Usacs Community Emergency Services Of Colorado Inc. | 2466711536 | 169 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
| Entity Name | Halifax Healthcare Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245283530 PECOS PAC ID: 1254238090 Enrollment ID: O20031218000443 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
| Entity Name | Florida Emergency Physicians Kang And Associates Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811983752 PECOS PAC ID: 0143113878 Enrollment ID: O20040205000687 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
| Entity Name | Pensacola Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801841473 PECOS PAC ID: 3173582624 Enrollment ID: O20041008000951 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20041207001148 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
| Entity Name | Paragon Emergency Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912101650 PECOS PAC ID: 8628153087 Enrollment ID: O20080310000143 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
| Entity Name | Tampa Bay Emergency Physicians-heartland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043661408 PECOS PAC ID: 0749577781 Enrollment ID: O20160920000442 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shelly Anne Birch, MD 3244 Riverview Ln, Port Orange, FL 32127-6269 Ph: (847) 975-1298 | Dr Shelly Anne Birch, MD 303 N Clyde Morris Blvd, Daytona Beach, FL 32114-2709 Ph: (386) 425-4100 |
News Archive
Commuters and workers on the London's Tube network, gearing up for another potentially suffocating summer below ground, can at least take some comfort from research in Occupational and Environmental Medicine.
In many cases, targeted therapies for cancer are preferred as treatments over chemotherapy and surgery because they attack and kill cancer cells with specific tumor-promoting mutations while sparing healthy, normal cells that do not express these mutations.
People experiencing sudden cardiac arrest at exercise facilities have a higher chance of survival than at other indoor locations, likely due to early CPR and access to an automated external defibrillator, among other factors, according to a study published online today in the Journal of the American College of Cardiology.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
OXIS INTERNATIONAL, INC. announced today that the Company has retained Quinn Emanuel Urquhart Oliver & Hedges ("Quinn Emanuel") to enforce all patents related to the unique benefits of its potent antioxidant compound L-Ergothioneine ("ERGO").
› Verified 2 days ago
Cheryl Marie Moses, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-4000 | |
Dr. Peter Springer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-2285 Fax: 386-425-1304 | |
Dr. Rewadee Soontharothai, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 303 North Clyde Morris Blvd., Halifax Health Medical Center, Daytona Beach, FL 32114 Phone: 386-425-2285 Fax: 386-425-7522 | |
Dr. Cindy May Hird, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 North Clyde Morris Blvd., Halifax Health Medical Center, Daytona Beach, FL 32114 Phone: 386-425-2285 Fax: 386-425-7522 | |
Jessica Gershen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Emergency Medicine, Daytona Beach, FL 32114 Phone: 386-425-2285 Fax: 386-425-7522 | |
Dr. Danielle Leanne Collins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-425-2285 Fax: 386-425-7522 | |
Steven Stone, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-425-4000 |